Kazuhiro Nako

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

Susumu Ogawa, Takefumi Mori, Kazuhiro Nako et al. · Hypertension · 2006 · 131 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Methylglyoxal Is a Predictor in Type 2 Diabetic Patients of Intima-Media Thickening and Elevation of Blood Pressure

Susumu Ogawa, Keisuke Nakayama, Masaaki Nakayama et al. · Hypertension · 2010 · 108 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Decreases Systolic Blood Pressure in Japanese Hypertensive Patients with Type 2 Diabetes

Susumu Ogawa, Mikihito Ishiki, Kazuhiro Nako et al. · The Tohoku Journal of Experimental Medicine · 2011 · 107 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Angiotensin II Type 1 Receptor Blockers Reduce Urinary Angiotensinogen Excretion and the Levels of Urinary Markers of Oxidative Stress and Inflammation in Patients with Type 2 Diabetic Nephropathy

Susumu Ogawa, Hiroyuki Kobori, Naro Ohashi et al. · Biomarker Insights · 2009 · 72 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

Miho Senda, Susumu Ogawa, Kazuhiro Nako et al. · Endocrine Journal · 2012 · 72 citations · Full text

Medicine, Endocrinology, Pharmacology +17